Compare ALGN & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGN | CELH |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.1B |
| IPO Year | N/A | N/A |
| Metric | ALGN | CELH |
|---|---|---|
| Price | $156.23 | $47.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 18 |
| Target Price | ★ $187.50 | $63.41 |
| AVG Volume (30 Days) | 1.2M | ★ 4.7M |
| Earning Date | 02-04-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.16 | 0.13 |
| Revenue | ★ $3,982,622,000.00 | $2,125,838,000.00 |
| Revenue This Year | $2.58 | $82.94 |
| Revenue Next Year | $3.36 | $32.22 |
| P/E Ratio | ★ $30.25 | $363.91 |
| Revenue Growth | 0.56 | ★ 55.07 |
| 52 Week Low | $122.00 | $21.10 |
| 52 Week High | $237.23 | $66.74 |
| Indicator | ALGN | CELH |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 59.18 |
| Support Level | $154.98 | $45.46 |
| Resistance Level | $159.16 | $47.08 |
| Average True Range (ATR) | 3.14 | 1.38 |
| MACD | -1.33 | 0.72 |
| Stochastic Oscillator | 11.73 | 99.71 |
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.